F-star Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2015 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
F-star Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2015 to Q3 2022.
  • F-star Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2022 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 200M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 200M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 200M 0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 200M 0 0% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 200M 0 0% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 200M 0 0% Dec 31, 2020 10-K 2022-03-15
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 200M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 200M 0 0% Dec 31, 2019 10-K 2021-03-30
Q3 2019 200M 0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 200M 0 0% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 200M 0 0% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 200M 0 0% Dec 31, 2018 10-K 2020-02-14
Q3 2018 200M 0 0% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 200M 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 200M 0 0% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 200M 0 0% Dec 31, 2017 10-K 2019-03-11
Q3 2017 200M 0 0% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 200M 0 0% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 200M +150M +300% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 200M +150M +300% Dec 31, 2016 10-K 2018-02-20
Q3 2016 200M Sep 30, 2016 10-Q 2016-10-28
Q2 2016 200M Jun 30, 2016 10-Q 2016-08-01
Q1 2016 50M Mar 31, 2016 10-Q 2016-06-15
Q4 2015 50M Dec 31, 2015 10-K 2017-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.